Cannabis and Exercise: Performance, Recovery, and the Evidence

Cannabis and Athletic Performance: What the Science Shows

• THC is prohibited in competition by WADA but permitted in out-of-competition periods
• CBD was removed from the WADA prohibited list in 2018
• Limited controlled research exists on the direct effects of cannabis on athletic performance metrics
• Anecdotal reports from athletes are mixed, with some reporting impaired coordination and reaction time

The relationship between cannabis and athletic performance is an area of growing interest, driven partly by changing legal landscapes and partly by high-profile athletes speaking publicly about their cannabis use. The scientific evidence base is limited by the historical illegality of cannabis, which has constrained research, and by the wide variability in preparation types, dosing, and individual responses. What evidence exists suggests that THC is unlikely to provide performance-enhancing effects in most athletic contexts.

Cannabis for Exercise Recovery

• Anti-inflammatory properties of cannabinoids may support post-exercise recovery processes
• Pain relief effects could reduce the impact of exercise-induced muscle soreness
• Sleep-improving effects of cannabis may indirectly support recovery through improved rest quality
• CBD-only products are used by a growing number of athletes without WADA prohibition concerns

Recovery is the arena in which cannabis has attracted the most sustained interest from the athletic and sports medicine communities. The combination of analgesic, anti-inflammatory, and sleep-supporting properties attributed to cannabinoids maps well onto the physiological demands of recovery from intense exercise. CBD, in particular, has been widely adopted by athletes at all levels as a recovery support supplement, driven by its removal from the WADA prohibited list and its perceived safety profile.

Pain Management in Sports Medicine

• Chronic musculoskeletal pain is common in both professional and recreational athletes
• Cannabis may offer an alternative or adjunct to NSAIDs and opioids for pain management
• The risk of opioid dependence in injured athletes makes non-opioid alternatives clinically relevant
• Sports medicine practitioners are increasingly encountering patients already using cannabis for pain

The opioid crisis has prompted significant interest in alternative analgesic strategies across medicine, including sports medicine. Medical cannabis represents one such alternative — offering meaningful pain relief for many patients without the addiction liability associated with opioid analgesics. Sports medicine practitioners managing athletes with chronic pain from injuries or overuse conditions are increasingly encountering cannabis as part of a broader pain management conversation.

Practical Advice for Active Patients on Medical Cannabis

• Patients should be counselled on WADA regulations and tested-sport implications before prescribing
• Timing of cannabis use relative to training and competition affects both performance and legal risk
• Hydration is particularly important during exercise for patients using cannabis
• Patients should report any unusual cardiovascular symptoms during exercise to their prescriber

Active patients on medical cannabis prescriptions have specific practical needs that general prescribing guidance may not address. WADA compliance, timing of dosing relative to training, cardiovascular monitoring during exercise, and hydration requirements are all relevant clinical considerations. Prescribers working with active patient populations should develop familiarity with these issues and include them as standard elements of the clinical consultation with patients who exercise regularly.